Toru Ogura

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Drug Administration

Molecular Dynamics

Top Venues

Clinical drug investigation

Journal of biopharmaceutical statistics

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Parameter estimation of Weibull distribution for the number of days between drug administration and early onset adverse event. Journal of biopharmaceutical statistics (2022)
Reiko Yamada, Shuji Isaji, Takehiro Fujii, Hiroyuki Sakurai, Masashi Kishiwada, Yasuhiro Murata, Aoi Hayasaki, Hiroyuki Inoue, Yuhei Umeda, Kyosuke Tanaka, Yasuhiko Hamada, Junya Tsuboi, Toshio Kato, Yoshihiro Kondo, Shinsuke Matsuda, Noriko Watanabe, Toru Ogura, Satoshi Tamaru
Improving the Prognosis of Pancreatic Cancer Through Early Detection: Protocol for a Prospective Observational Study. JMIR research protocols 10 (10) (2021)